Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
11/25/1999 | WO1999060024A1 Methods for amyloid removal using anti-amyloid antibodies |
11/25/1999 | WO1999060023A1 Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases |
11/25/1999 | WO1999060021A2 Use of activated t cells, nervous system-specific antigens for treating disorders of the nevrous system |
11/25/1999 | WO1999060017A2 Human tumour-derived polypeptide hormone phosphatonin |
11/25/1999 | WO1999059636A1 Vegf activity inhibitors |
11/25/1999 | WO1999059633A1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody |
11/25/1999 | WO1999059632A1 Methods and use of compositions comprising tnf-rii(p75) agonists for treating asthma and other allergic conditions |
11/25/1999 | WO1999059631A1 Prevention and treatment of hypergastrinemia |
11/25/1999 | WO1999059630A1 Type iii bordetella secretion system |
11/25/1999 | WO1999059629A1 Humanized antibodies that recognize verotoxin ii and cell line producing same |
11/25/1999 | WO1999059628A2 Combination therapy for the treatment of tumors |
11/25/1999 | WO1999059627A2 Verotoxin b subunit for immunization |
11/25/1999 | WO1999059626A1 Compositions and method for immunizing poultry |
11/25/1999 | WO1999059625A1 Vaccine delivery system |
11/25/1999 | WO1999059624A2 Composition for inducing a tumor-specific immune response, method for the production and utilization of said composition in the treatment of neoplasia |
11/25/1999 | WO1999059618A1 Acrp30r1l, a homolog of acrp30 (30 kd adipocyte complement-related protein) |
11/25/1999 | WO1999059612A1 Method for the treatment of gastroesophageal reflux disease |
11/25/1999 | WO1999059608A2 Osteoporosis treatment |
11/25/1999 | WO1999059560A1 Glucose transport modulators and uses therefor |
11/25/1999 | WO1999059500A2 Apparatus and methods for preparing an implantable graft |
11/25/1999 | WO1999048523A3 Antagonists of the inflammatory mediator oncostatin m (osm) |
11/25/1999 | WO1999048515A9 Trimeric antigenic o-linked glycopeptide conjugates, methods of preparation and uses thereof |
11/25/1999 | WO1999047925A3 Methods and compositions for diagnosis of rheumatoid arthritis |
11/25/1999 | WO1999045957A3 Combined vaccine compositions |
11/25/1999 | WO1999043832A3 Human proteinase molecules |
11/25/1999 | WO1999040881A3 Specific antibodies against mammary tumor-associated mucin, method for production and use |
11/25/1999 | WO1999038976A3 Human growth factor homologs |
11/25/1999 | WO1999035271A3 Vibrio cholerae vaccine candidates and method of their constructing |
11/25/1999 | WO1999005527A3 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens |
11/25/1999 | DE19823097A1 Pharmaceutical comprising an alpha-protein |
11/25/1999 | DE19806803A1 Transporter für Saccharid-gekoppelte Zytostatika in Tumorzellen Transportation for saccharide-linked cytotoxic agents in tumor cells |
11/25/1999 | CA2333921A1 Verotoxin b subunit for immunization |
11/25/1999 | CA2333144A1 Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases |
11/25/1999 | CA2332774A1 Method for the treatment of gastroesophageal reflux disease |
11/25/1999 | CA2332331A1 Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases |
11/25/1999 | CA2332246A1 Compositions and method for immunizing poultry |
11/25/1999 | CA2329868A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products |
11/25/1999 | CA2329153A1 Novel g-protein coupled receptor |
11/25/1999 | CA2329139A1 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof |
11/25/1999 | CA2328893A1 Vegf activity inhibitors |
11/25/1999 | CA2328527A1 Secreted proteins |
11/25/1999 | CA2328509A1 Methods and use of compositions comprising tnf-rii(p75) agonists for treating asthma and other allergic conditions |
11/25/1999 | CA2328501A1 Prevention and treatment of hypergastrinemia |
11/25/1999 | CA2328057A1 Composition for the induction of a tumour-specific immune response, methods for its production and use of composition for the treatment of neoplasia |
11/25/1999 | CA2325600A1 Methods for amyloid removal using anti-amyloid antibodies |
11/24/1999 | EP0959129A1 Drugs for treating exocrine gland disorders and transgenic mice to be used for screening the same |
11/24/1999 | EP0959079A1 Vaccine for the reversible immunocastration of mammals |
11/24/1999 | EP0958834A1 Peptide immunotherapeutic agent |
11/24/1999 | EP0958382A2 Novel method for testing the differentiation status in pancreatic cells of a mammal |
11/24/1999 | EP0958374A1 T1 receptor-like ligand i |
11/24/1999 | EP0958373A1 Vaccines |
11/24/1999 | EP0958364A1 Immunotherapy and improved vaccines |
11/24/1999 | EP0958304A1 Nucleotide sequence encoding the cd33-like protein |
11/24/1999 | EP0957941A1 USE OF A MELANOMA DIFFERENTIATION ASSOCIATED GENE (mda-7) FOR REVERSING A CANCEROUS PHENOTYPE |
11/24/1999 | EP0957937A1 VACCINES, ANTIBODIES, PROTEINS, GLYCOPROTEINS, DNAS AND RNAS FOR PROPHYLAXIS AND TREATMENT OF $i(CRYPTOSPORIDIUM PARVUM) INFECTIONS |
11/24/1999 | EP0957936A1 Formulations of recombinant papillomavirus vaccines |
11/24/1999 | EP0957935A1 Chlamydial vaccines and immunogenic compositions containing an outer membrane antigen and methods of preparation thereof |
11/24/1999 | EP0957934A1 Targeting antigens to the mhc class i processing pathway with anthrax toxin fusion protein |
11/24/1999 | EP0957933A1 Vaccine composition against malaria |
11/24/1999 | EP0822831B1 Vaccines containing a saponin and a sterol |
11/24/1999 | CN1236391A Method for producing recombinants intended for use in a complete malaria antigene gp 190/MSP1 |
11/24/1999 | CN1236321A Acellular pertussis vaccine with diphthriae- and tetanus-toxoids |
11/24/1999 | CN1235847A Method for preparing epidemic hemorrhagic fever vaccine |
11/24/1999 | CN1046737C Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for determination thereof |
11/23/1999 | US5990285 Catalytic antibodies against cocaine |
11/23/1999 | US5990282 Receptor protein for human B cell stimulatory factor-2 |
11/23/1999 | US5990274 Cyclosporine derivatives and uses thereof |
11/23/1999 | US5990149 Photodynamic therapy; using triacid form of the monohydrobenzoporphyrin class; antitumor, carcinogenic, arthritic agents; atherosclerosis; restenosis; blood infections; skin disorders; vision defects |
11/23/1999 | US5990085 Inhibin-HBc fusion protein |
11/23/1999 | US5989922 Method for determining rheumatoid factors and agents for carrying out the method |
11/23/1999 | US5989907 Methods and compositions for calcium binding proteolipid encoding nucleic acids |
11/23/1999 | US5989886 Method for the inhibition and prevention of viral replication using fusions of a virus protein and a destructive enzyme |
11/23/1999 | US5989884 Polypeptides of the histidyl transfer rna synthetase family; for screening of antibiotics, bactericides, and bacteristats for treatment and prevention of clamydial infections; diagnosis |
11/23/1999 | US5989867 Purified genes, proteins, and antibodies; diagnostic kits; genetic engineering |
11/23/1999 | US5989865 In vitro detection of antibodies against protein variant having arginine in position 145 of the amino acid sequence |
11/23/1999 | US5989864 DNA encoding spo-rel polypeptides |
11/23/1999 | US5989861 Human ion transport-like protein |
11/23/1999 | US5989858 Dead-type ATP-dependent RNA helicase (DbpB) from Staphylococcus aureus |
11/23/1999 | US5989848 Use of human immortalized endothelial cells to isolate and propagate Ehrlichia chaffeensis and Ehrlichia canis |
11/23/1999 | US5989838 Immunological methods of detecting MN proteins and MN polypeptides |
11/23/1999 | US5989830 Bifunctional or bivalent antibody fragment analogue |
11/23/1999 | US5989828 Binding to matrix; vaccines |
11/23/1999 | US5989805 Immortal avian cell line to grow avian and animal viruses to produce vaccines |
11/23/1999 | US5989804 E6 binding proteins |
11/23/1999 | US5989803 Method for treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase |
11/23/1999 | US5989584 CCK antibodies used to improve feed efficiency |
11/23/1999 | US5989566 Stable vaccine compositions for parenteral administration, a method for their use, and a process for their preparation |
11/23/1999 | US5989565 Elution and identification of T cell epitopes from viable cells |
11/23/1999 | US5989564 Pertussis toxoid made by reacting pertussis toxin with the nitrating agent TNM |
11/23/1999 | US5989563 Viral agent associated with mystery swine disease |
11/23/1999 | US5989562 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
11/23/1999 | US5989561 Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (RHDV) compositions and uses |
11/23/1999 | US5989554 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
11/23/1999 | US5989553 Expression library immunization |
11/23/1999 | US5989552 Antigen carbohydrate compounds and their use in immunotherapy |
11/23/1999 | US5989551 Materials and methods for detection and treatment of insulin-dependent diabetes |
11/23/1999 | US5989550 Materials and methods for immunocontraception |
11/23/1999 | US5989549 Acrosomal sperm protein and uses thereof |
11/23/1999 | US5989548 Peptide-based composition against papillomavirus infection |
11/23/1999 | US5989547 Leptospiral outer membrane proteins |